Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials ASCO Guidelines provide recommendations with comprehensive ...
The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Collaboration brings whole-exome based hereditary cancer insights to urologists and their patients by offering it alongside Veracyte's Decipher Prostate Test The partnership was also highlighted ...
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) ...
NHS England will collect patient information on 100 genes linked to an increased risk of cancer, in a bid to identify those ...
The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common cancer among men worldwide, and ranks first in Europe, where a third ...
NHS England » Thousands at risk of inherited cancers to receive regular NHS checks through world-first genetics programme ...
Ahead of the government’s landmark new National Cancer Plan next month, England’s top cancer doctor said the genetic register ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results